MaxCyte CCO Ali Soleymannezhad departs effective August 11, 2025; receives nine-month severance

MAXCYTE, INC.

Ali Soleymannezhad's employment as Chief Commercial Officer ended on August 11, 2025.
Severance includes base salary for nine months and COBRA contributions during the severance period.
Severance is contingent on execution and effectiveness of a release of claims and continued compliance.
No replacement for the Chief Commercial Officer has been announced.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.